Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

JAZZ - Jazz Pharmaceuticals plc


IEX Last Trade
115.9
0.300   0.259%

Share volume: 365,740
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$115.60
0.30
0.26%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
42%
Profitability 25%
Dept financing 28%
Liquidity 75%
Performance 54%
Company vs Stock growth
vs
Performance
5 Days
1.85%
1 Month
3.30%
3 Months
9.98%
6 Months
-10.58%
1 Year
-20.18%
2 Year
-23.77%
Key data
Stock price
$115.90
P/E Ratio 
18.14
DAY RANGE
N/A - $116.80
EPS 
$5.78
52 WEEK RANGE
$99.06 - $143.32
52 WEEK CHANGE
-$0.19
MARKET CAP 
7.162 B
YIELD 
N/A
SHARES OUTSTANDING 
61.754 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
0.46
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$384,966
AVERAGE 30 VOLUME 
$488,604
Company detail
CEO: Bruce Cozadd
Region: US
Website: https://www.jazzpharma.com/
Employees: 3,199
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni

Recent news